Spherix Announces Positive Type 2 Diabetes News

Image via Wikipedia

PR NewsWire's Coverage of Spherix

Positive Clinical Trial Results were concluded for Type 2 Diabetes. This stock is a buy right now. It is very low priced. Trading was halted today. Expect modest returns tomorrow October 8th.  This is a competitive market for Diabetes Drugs.  Hopefully, getting FDA Approval soon could allow a gain in Market Share.

Spherix Announces Statistically Significant Results in Phase 3 Study With D-tagatose in Type 2 Diabetes

Market Thoughts for Wednesday August 11th

The market took a hammering today but some stocks actually performed or are now great buys. The DOW Industrial average DIJA is closing sharply lower today at 10379. That's a 265 drop from yesterdays close of 10644 and a 2.49% decline as Global Fear strikes domestic and foreign markets.

Today's top performers in BioPharma for August 11th.

Biotech